Market Overview:
The global contraceptive drug market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing awareness about contraception, rising prevalence of sexually transmitted infections (STIs), and growing demand for long-acting reversible contraceptives (LARCs). Based on type, the global contraceptive drug market is segmented into oral contraceptives, contraceptive injectable, and topical contraceptive patch. Oral contraceptives are further sub-segmented into combined oral contraceptives and progestin-only oral contraceptives. Contraceptive injectable is further sub-segmented into depot medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN). Topical contraceptive patch is further sub-segmented into transdermal patches containing ethinyl estradiol/levonorgestrel combination and transdermal patches containing norelgestromin/ethinyl estradiol combination. Based on application, the global contraceptive drug market is segmented into hospital pharmacy, independent pharmacy, online platform, clinics, and others. Geographically, the global contraceptive drug market is segmented into North America,, Latin America,, Europe,, Asia Pacific,, Middle East & Africa,. North America accounted for the largest share of the global contraception drugs in 2017 owing to high prevalence of STIs coupled with increasing awareness about contraception among women in this region.
Product Definition:
A contraceptive drug is a medication taken to prevent pregnancy. They come in many forms, including birth control pills, patches and rings. The important thing about contraceptive drugs is that they are extremely effective at preventing unwanted pregnancies when used correctly.
Oral Contraceptives:
Oral Contraceptives, also known as Pills or Oral Sex Drugs, are drugs that prevent pregnancy. They may also help in avoiding ovulation. The most common types of oral contraceptives are the Pill (ethinyl estradiol and norethindrone), vaginal rings (e.g., Ortho-Cyclen), and tablets/creams (e.g., estrogen).
Contraceptive Injectable:
Contraceptive Injectable is a long-acting reversible hormonal method of contraception. It is also known as the birth control injection or the hormone injectable. The contraceptive injectable consists of an estrogen and a progesterone mix that works by stopping egg development and thickening cervical mucous to prevent sperm from reaching the uterus.
The major advantages of using contraceptive injections are it can be used for up to three years, has very few adverse effects, no effect on breastfeeding.
Application Insights:
The application segment includes hospital pharmacy, independent pharmacy, online platform, and clinics. The hospital pharmacies dominate the market in terms of application as most of the contraceptives are sold through this channel. However, online platforms are expected to witness lucrative growth over the forecast period due to increasing use of technology such as e-mail and website for purchasing medicines with less effort and time consumed.
Contraceptive injectable accounted for a significant share in 2017 owing to its high effectiveness compared to oral methods; easy availability; low cost; convenience; ability to be used long term or lifelong depending on user requirements such as weight gain/losses etc.; no need for daily dosage adjustment like pills do when combined hormonal contraceptives (CHC) are taken continuously throughout a woman's reproductive life span preventing her from becoming pregnant. CHC users who take them continuously may experience breakthrough pregnancy during future attempts at conception leading towards increased usage of long acting reversible contraceptive (LARC).
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market during the forecast period. The growth of this region can be attributed to increasing awareness regarding contraceptive measures, rising population, and growing disposable income. According to WHO, in 2016 more than half of all women in China were using contraception; however, only 6% of them used modern methods (injectables and implants). In India about 9 million women use oral contraceptives while 5 million rely on injectables or implants (Hormonal Contraceptive Drugs in India Market Size & Trends Analysis Report 2017). Thus these factors are anticipated to boost the market for contraceptive drugs in APAC over the forecast period.
In Latin America also there has been a significant rise in usage rates for contraceptives such as IUDs.
Growth Factors:
- Increasing awareness about contraception and family planning methods
- Rising number of women in the workforce
- Growing prevalence of sexually transmitted infections (STIs)
- Government initiatives to promote contraceptive use among couples
- Technological advancements in contraceptive drug delivery systems
Scope Of The Report
Report Attributes
Report Details
Report Title
Contraceptive Drug Market Research Report
By Type
Oral Contraceptives, Contraceptive Injectable, Topical Contraceptive Patch
By Application
Hospital Pharmacy, Independent Pharmacy, Online Platform, Clinics
By Companies
Cipla, Bayer, Merck, Teva Pharmaceutical, Allergan, Pfizer, Reckitt Benckiser, Mankind Pharma, Janssen Pharmaceutical, HLL Lifecare, Cipla
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Contraceptive Drug Market Report Segments:
The global Contraceptive Drug market is segmented on the basis of:
Types
Oral Contraceptives, Contraceptive Injectable, Topical Contraceptive Patch
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Independent Pharmacy, Online Platform, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cipla
- Bayer
- Merck
- Teva Pharmaceutical
- Allergan
- Pfizer
- Reckitt Benckiser
- Mankind Pharma
- Janssen Pharmaceutical
- HLL Lifecare
- Cipla
Highlights of The Contraceptive Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Contraceptives
- Contraceptive Injectable
- Topical Contraceptive Patch
- By Application:
- Hospital Pharmacy
- Independent Pharmacy
- Online Platform
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Contraceptive Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A contraceptive drug is a medication that is used to prevent pregnancy. There are many different types of contraceptive drugs, each with its own set of benefits and drawbacks. Some common types of contraceptives include birth control pills, condoms, diaphragms, and spermicides.
Some of the major companies in the contraceptive drug market are Cipla, Bayer, Merck, Teva Pharmaceutical, Allergan, Pfizer, Reckitt Benckiser, Mankind Pharma, Janssen Pharmaceutical, HLL Lifecare, Cipla.
The contraceptive drug market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contraceptive Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Contraceptive Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Contraceptive Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Contraceptive Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Contraceptive Drug Market Size & Forecast, 2020-2028
4.5.1 Contraceptive Drug Market Size and Y-o-Y Growth
4.5.2 Contraceptive Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral Contraceptives
5.2.2 Contraceptive Injectable
5.2.3 Topical Contraceptive Patch
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Independent Pharmacy
6.2.3 Online Platform
6.2.4 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Contraceptive Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Contraceptive Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral Contraceptives
9.6.2 Contraceptive Injectable
9.6.3 Topical Contraceptive Patch
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Independent Pharmacy
9.10.3 Online Platform
9.10.4 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral Contraceptives
10.6.2 Contraceptive Injectable
10.6.3 Topical Contraceptive Patch
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Independent Pharmacy
10.10.3 Online Platform
10.10.4 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral Contraceptives
11.6.2 Contraceptive Injectable
11.6.3 Topical Contraceptive Patch
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Independent Pharmacy
11.10.3 Online Platform
11.10.4 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral Contraceptives
12.6.2 Contraceptive Injectable
12.6.3 Topical Contraceptive Patch
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Independent Pharmacy
12.10.3 Online Platform
12.10.4 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral Contraceptives
13.6.2 Contraceptive Injectable
13.6.3 Topical Contraceptive Patch
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Independent Pharmacy
13.10.3 Online Platform
13.10.4 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Contraceptive Drug Market: Competitive Dashboard
14.2 Global Contraceptive Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cipla
14.3.2 Bayer
14.3.3 Merck
14.3.4 Teva Pharmaceutical
14.3.5 Allergan
14.3.6 Pfizer
14.3.7 Reckitt Benckiser
14.3.8 Mankind Pharma
14.3.9 Janssen Pharmaceutical
14.3.10 HLL Lifecare
14.3.11 Cipla
